PAH

Is Merck Moving Toward Another Blockbuster Drug Launch?
Motley Fool
Wed, 10/26/22 - 10:32 am
Merck
sotatercept
PAH
Merck nails phase 3 sotatercept win, making good on its $11.5B Acceleron buy
Fierce Biotech
Mon, 10/10/22 - 11:06 am
Merck
Acceleron
clinical trials
sotatercept
PAH
pulmonary arterial hypertension
Long after first nod for inhaled Tyvaso, United Therapeutics scraps PhIII in PH with COPD
Endpoints
Tue, 09/20/22 - 10:32 am
Tyvaso
United Therapeutics
PAH
clinical trials
FDA declines to approve United-MannKind's lung disease therapy
Yahoo/Reuters
Mon, 10/18/21 - 10:42 pm
MannKind
United Therapeutics
Tyvaso
FDA
PAH
Is an Acquisition of Acceleron a Smart Move for Merck?
Motley Fool
Fri, 10/8/21 - 10:35 am
Merck
M&A
Acceleron
PAH
Keytruda
Merck & Co justifies paying up for Acceleron
EP Vantage
Fri, 10/1/21 - 10:46 am
Merck
Accleron
M&A
sotatercept
Reblozyl
PAH
Merck Strikes with $11 Billion Deal for Acceleron and Phase III PAH Drug
BioSpace
Thu, 09/30/21 - 12:01 am
Merck
Acceleron
M&A
PAH
Merck emerges as lead bidder in potential Acceleron buyout with deal possible this week — report
Endpoints
Tue, 09/28/21 - 12:15 am
Merck
Acceleron
M&A
PAH
sotatercept
MannKind and United Snag Priority Review for Pulmonary Hypertension Drug
BioSpace
Wed, 06/16/21 - 11:17 pm
MannKind
United Therapeutics
PAH
PH-ILD
FDA
priority review
Tyvaso
Acceleron uncorks more mid-stage data for PAH drug sotatercept as part of the drug's resurrection campaign
Endpoints
Wed, 05/19/21 - 10:42 am
Acceleron
sotatercept
PAH
J&J aims to create community for PAH patients and their doctors with new Uptravi campaign
Fierce Pharma
Tue, 05/18/21 - 10:59 am
JNJ
PAH
Uptravi
pharma marketing
United axes PAH program Trevyent, once bought for cheap in acquisition of a rival, after FDA feedback
Endpoints
Wed, 03/3/21 - 10:57 am
United Therapeutics
Trevyent
PAH
SteadyMed
With pipeline setbacks mounting, United snares priority voucher for inhaled formulation of PAH med Tyvaso
Endpoints
Mon, 12/28/20 - 10:47 am
United Therapeutics
Tyvaso
priority review voucher
PAH
Bayer’s Adempas meets primary endpoint in phase 4 trial in PAH patients
Pharmaceutical Business Review
Tue, 09/8/20 - 10:43 am
Adempas
Bayer
PAH
clinical trials
Acceleron's PAH drug gets the FDA's red carpet treatment with breakthrough status
Endpoints
Wed, 04/8/20 - 10:37 am
Acceleron
PAH
FDA
breakthrough therapy
sotatercept
Reata Pharmaceuticals Says Ongoing Trials In Patients With Pulmonary Arterial Hypertension Stopped Due To High Risk Of COVID-19 To These Patients
Reuters
Mon, 03/30/20 - 08:18 pm
Reata Pharmaceuticals
PAH
clinical trials
COVID-19
Acceleron’s post-Reblozyl plan comes together
EP Vantage
Tue, 01/28/20 - 11:09 am
Acceleron
sotatercept
PAH
JNJ
Bellerophon Therapeutics
United Therapeutics
Vivus
Arena
Novartis
Acceleron Shares Surge as Its Hypertension Drug Meets Trial Endpoints
Motley Fool
Mon, 01/27/20 - 10:47 pm
Acceleron
PAH
clinical trials
sotatercept
Acceleron gets FDA orphan drug designation for sotatercept in pulmonary arterial hypertension
Pharmaceutical Business Review
Tue, 09/10/19 - 11:06 am
Acceleron
orphan drugs
sotatercept
PAH
United Therapeutics Fires Back After Sandoz Files Anti-Competitive Lawsuit Over PAH Drug
BioSpace
Fri, 04/19/19 - 05:53 pm
United Therapeutics
PAH
Remodulin
generics
Sandoz

Pages